Fact CheckerSign in

NCT06233253Completed

Online Mindfulness-Based Intervention to Decrease Pre-Procedural Anxiety Before a First-Time Screening Colonoscopy

A Brief Online Mindfulness-Based Intervention to Decrease Pre-Procedural Anxiety Before a First-Time Screening Colonoscopy: A Pilot Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 24 Feb 2025

Brief summary (registry, in English)

This clinical trial tests how well an online mindfulness-based intervention (MBI) works to decrease anxiety in patients before a first-time screening colonoscopy. Elevated pre-procedural anxiety can affect patient outcomes including bowel preparation adherence and quality, the amount of sedation required, procedure time, patient satisfaction, cancellation or no-shows, and intention for future cancer screening. Mindfulness is a form of meditation that focuses on staying within the present moment to reduce anxiety. Previous research supports mindfulness practice among cancer survivors to decrease anxiety, fear of cancer re-occurrence, and to improve quality of life. Online MBIs have the potential to include targeted meditations and educational information designed to promote behavior change. This study may help researchers learn whether a mindfulness intervention works to decrease anxiety in patients before a first-time screening colonoscopy.

Status (registry)
Completed
Study type
Interventional
Enrollment
100 (actual)
First submitted
8 Jan 2024
Start date
29 Sept 2023
Primary completion date
12 Jul 2024
Lead sponsor
Ohio State University Comprehensive Cancer Center
NCT number
NCT06233253

What you commit to

  • Study type: Interventional
  • Participants enrolled: 100
  • From 29 Sept 2023 to the primary completion date, 12 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous colonoscopy
  • Previous diagnosis of a mental health disorder

Other illness

  • Auditory or visual impairment that prevents internet use
  • Previous cancer diagnosis (other than skin cancer)
  • Family history of CRC
  • Personal history of inflammatory bowel disease (ulcerative colitis or Crohn's disease)
  • Confirmed or suspected hereditary CRC syndrome, such as familial adenomatous polyposis or Lynch syndrome

Other

  • Colonoscopy for diagnostic purposes
  • Current mental health treatment

Who the study is looking for

  • Patients must be ages 45-75
  • Patients must be at average risk for colorectal cancer (CRC)
  • Patients must have scheduled their first-time screening colonoscopy as an outpatient at Ohio State University (OSU) at least 14 days in advance
  • Patients must be able to speak and read English
  • Patients must have daily access to a working telephone, email address, and internet connection
  • Patients must provide consent

Age in the registry: 45 years to 75 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ohio State University Comprehensive Cancer Center
Coordinator of this site? Confirm its status
ColumbusUnited StatesUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.